SelinaLugerMD

PubMed

• Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
  Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Ximena Jordan Bruno, Catherine E Lai, Alison W Loren, Selina M Luger, Andrew H Ma...> ;Haematologica. 2024 Apr 18
• Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
  Barr, P. M., Barr, P. M., Barr, P. M., Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Na...> ;Blood. 2024 Apr 18
• mutations in acute myeloid leukemia.
  Corey Poveda-Rogers, Jennifer J D Morrissette, Dorottya Laczko, Andrew H Matthews, Oraine Snaith, Selina Luger, Adam Bagg, Gabriel C Caponetti, Guang Yang> ;Leukemia & Lymphoma. 2024 Mar 20
• Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.
  Freyer, C., Carulli, A., Frey, N., Martin, M., Porter, D., Loren, A., Gill, S., Hexner, E., Luger, S., Stadtmauer, E.> ;Leukemia & Lymphoma. 2024 Feb 1
• Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
  Anthony D Sung, Thuy Koll, Shannon H Gier, Alessandro Racioppi, Griffin White, Meagan Lew, Marcia Free, Priyal Agarwal, Lauren M Bohannon, Ernaya J Johnson, Bharathi S...> ;Transplantation and Cellular Therapy. 2024 Apr 1
• Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
  Altman, J., Zuckerman, T., Koprivnikar, J., McCloskey, J., Kota, V., Keng, M., Frankfurt, O., Abaza, Y., Bixby, D., Emadi, A., Burch, M., Bhatnagar, B., Luger, S., Per...> ;Blood Advances. 2023 Dec 26
• 1 citations
  A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
  Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litz...> ;Leukemia. 2024 Jan 1
• One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
  Lindsey Chippendale, Craig W Freyer, Alison Carulli, Daria V Babushok, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Selina M Luger, Mary Ellen Martin, David L Porte...> ;Journal of Oncology Pharmacy Practice. 2023 Aug 21
• 1 citations
  The New NCI Precision Medicine Trials.
  Lyndsay N Harris, Charles D Blanke, Harry P Erba, James M Ford, Robert J Gray, Michael L LeBlanc, Siwen Hu-Lieskovan, Mark R Litzow, Selina M Luger, Funda Meric-Bernst...> ;Clinical Cancer Research. 2023 Dec 1
• 8 citations
  Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia.
  Velasquez, P., Velasquez, P., Chun Shik Park, Hiroki Yoshihara, Qingsong Gao, Chunxu Qu, Ilaria Iacobucci, Pankaj S Ghate, Jon P Connelly, Shondra M Pruett-Miller, Ben...> ;Cell Reports. 2023 Jul 25
• 3 citations
  Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
  Andrew H Matthews, Alexander E Perl, Selina M Luger, Saar I Gill, Catherine Lai, David L Porter, Sarah Skuli, Ximena Jordan Bruno, Martin P Carroll, Craig W Freyer, Al...> ;American Journal of Hematology. 2023 Aug 1
• 4 citations
  Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
  Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P R...> ;Blood Advances. 2023 Oct 10
• Is blinatumomab now standard of care consolidation for patients with ALL?
  Selina M Luger> ;Clinical Advances in Hematology & Oncology. 2023 Jun 1
• Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?
  Robert D Schwab, Selina M Luger> ;Current Treatment Options in Oncology. 2023 Jul 1
• 1 citations
  Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.
  James M Foran, Zhuoxin Sun, Catherine Lai, Hugo F Fernandez, Larry D Cripe, Rhett P Ketterling, Janis Racevskis, Selina M Luger, Elisabeth Paietta, Hillard M Lazarus, ...> ;Cancer. 2023 Aug 15
• 1 citations
  Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
  Matthew P Connor, Alison W Loren, Elizabeth O Hexner, Mary Ellen Martin, Saar I Gill, Selina M Luger, James K Mangan, Alexander E Perl, Shannon R McCurdy, Keith W Prat...> ;Transplantation and Cellular Therapy. 2023 Feb 1
• 3 citations
  The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study.
  Ibrahim Aldoss, Jun Yin, Anna Wall, Krzysztof Mrózek, Michaela Liedtke, David F Claxton, Matthew C Foster, Frederick R Appelbaum, Harry P Erba, Mark R Litzow, Martin S...> ;Blood Advances. 2023 Jan 24
• 5 citations
  An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
  Mohamed L Sorror, Ted A Gooley, Barry E Storer, Aaron T Gerds, Mikkael A Sekeres, Bruno C Medeiros, Eunice S Wang, Paul J Shami, Kehinde Adekola, Selina Luger, Maria R...> ;Blood. 2023 Jan 19
• 1 citations
  Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.
  Chezi Ganzel, Zhuoxin Sun, Timour Baslan, Yanming Zhang, Mithat Gönen, Omar I Abdel-Wahab, Janis Racevskis, Francine Garrett-Bakelman, Scott W Lowe, Hugo F Fernandez, ...> ;Leukemia Research. 2022 Dec 1
• 3 citations
  Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy.
  Bethany J Lockwood, Areej El-Jawahri, Alison R Walker, Sarah Ehrman, Deborah Russell, Sachin S Kale, Jillian Gustin, Seuli Bose-Brill, Thomas W LeBlanc, Selina M Luger...> ;Journal of Adolescent and Young Adult Oncology. 2023 Aug 1
• 3 citations
  Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid Leukemia.
  Hermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, Monica H Bodd, Matthew J Reynolds, Ashley M Nelson, Richard Newcomb, Tejaswini M Dhawale, Daniel Yang, Selina M ...> ;Journal of the National Comprehensive Cancer Network. 2022 Oct 1
• 4 citations
  Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis.
  Craig W Freyer, Daria V Babushok, Noelle V Frey, Saar I Gill, Alison W Loren, Selina M Luger, Amit Maity, Mary Ellen Martin, John P Plastaras, David L Porter, Elizabet...> ;Transplantation and Cellular Therapy. 2022 Sep 1
• 7 citations
  Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
  Lori Muffly, Jun Yin, Sawyer Jacobson, Anna Wall, Elisa Quiroz, Anjali S Advani, Selina M Luger, Martin S Tallman, Mark R Litzow, Matthew C Foster, Harry P Erba, Frede...> ;Blood Advances. 2022 Jul 26
• 33 citations
  Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
  Andrew H Matthews, Alexander E Perl, Selina M Luger, Alison W Loren, Saar I Gill, David L Porter, Daria V Babushok, Ivan P Maillard, Martin P Carroll, Noelle V Frey, E...> ;Blood Advances. 2022 Jul 12
• 14 citations
  Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
  Shunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci, Yaqi Zhao, Qingsong Gao, Elisabeth M Paietta, Claudia Haferlach, A Douglas Laird, Paul E Mead, Zhaohui Gu, Wendy...> ;Blood. 2022 Jun 16
• Join now to see all

Journal Articles

• Effectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia  
  Areej El-Jawahri, Thomas W Leblanc, Selina M Luger, Bhavana Bhatnagar, Alison R Walker, Amir T Fathi, Andrew M Brunner, Gabriela S Hobbs, Jennifer S Temel, JAMA Oncology
• Extramedullary Acute Myeloid Leukemia Presenting in Young Adults Demonstrates Sensitivity to High Dose Anthracycline: Subset Analysis from ECOG-ACRIN 1900  
  Selina M Luger, Ross L Levine, Martin S Tallman, Haematologica
• Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium Difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients  
  Edward A Stadtmauer, James K Mangan, Elizabeth O Hexner, David L Porter, Daria V Babushok, Jacqueline Smith, Craig W Freyer, Mindy Schuster, Noelle V Frey, Selina M Lu..., Clinical Infectious Diseases
• Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia  
  Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature
• Join now to see all

Abstracts/Posters

• Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young ...
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Dynamic Assembly of a Feedback Complex to Regulate Oncogenic B-Cell Receptor-Signaling
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Genomic Profiling in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Following HMA Failure: Baseline Results from the Inspire Study (04-30)
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integr...
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Inspire Study in Higher-Risk Myelodysplastic Syndrome (HR-MDS): A Novel Phase 3 Study Adaptive Design for Hematological Malignancies in Adults
  Selina M. Luger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Phase II Randomized Trial of Gilteritinib Vs Midostaurin in Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AML) 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Meet the Blood Editors 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients with Myelodysplastic Syndromes (MDS): Results of a L... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all